⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7730742 | 0.79 | LMNA (0.60) | — | |
| SCHEMBL11523890 | 0.77 | — | — | |
| SCHEMBL13409663 | 0.73 | — | — | |
| SCHEMBL37218 | 0.73 | — | — | |
| SCHEMBL14980830 | 0.73 | — | — | |
| SCHEMBL3318330 | 0.73 | — | — | |
| SCHEMBL3414553 | 0.73 | — | — | |
| SCHEMBL9390648 | 0.71 | — | — | |
| Ether SCHEMBL9720166 | 0.71 | LMNA (0.50) | — | |
| Hydrochloric Acid SCHEMBL11087182 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107001449-A | The composition of immunogenicity with reduction | 芝诺锡拉公司 | 2017-08-01 | — | — | CN | disclosed |
| CN-106535930-A | Porcine epidemic diarrhea virus vaccines and methods of use thereof | 明尼苏达大学董事会 | 2017-03-22 | — | — | CN | disclosed |
| CN-103608031-A | Methods for treating IFN alpha-related conditions | NEOVACS | 2014-02-26 | — | — | CN | disclosed |
| CN-103491978-A | Therapeutic compositions for treating glioblastoma | UNIV MINNESOTA | 2014-01-01 | — | — | CN | disclosed |
| CN-103347536-A | Strongly inactivated and still highly immunogenic vaccine and process of manufacturing thereof | NEOVACS | 2013-10-09 | — | — | CN | disclosed |
| CN-1679929-B | Streptococcal c5a peptidase vaccine | UNIV MINNESOTA A MINNESOTA COR | 2012-09-26 | — | — | CN | disclosed |
| CN-102186502-A | Immunological composition | WYETH CORP | 2011-09-14 | — | — | CN | disclosed |
| CN-101495139-A | Differentiating therapeutic composition | DIVA SOLUTIONS PTY LTD (AU) | 2009-07-29 | — | — | CN | disclosed |
| CN-101316610-A | Immunogenic fragments of T cell receptor constant regions and peptides derived therefrom | COHEN IRUN R (IL) | 2008-12-03 | — | — | CN | disclosed |
| CN-101222941-A | Method for preparing a stable immunogenic product comprising antigenic heterocomplexes of TNF alpha and a carrier protein | NEOVACS (FR) | 2008-07-16 | — | — | CN | disclosed |
| CN-1224422-C | Vaccines comprising interleukin-12 and herpes simplex viral antigen | WYETH CORP (US) | 2005-10-26 | — | — | CN | disclosed |
| CN-1679929-A | Streptococcal c5a peptidase vaccine | UNIV MINNESOTA A MINNESOTA COR (US) | 2005-10-12 | — | — | CN | disclosed |
| CN-1200730-C | Pneumococcal and Meningococcal vaccines formulated with interleukin-12 | WYETH CORP (US) | 2005-05-11 | — | — | CN | disclosed |
| CN-1299287-A | Vaccines comprising interleukin-12 and herpes simplex viral antigen | AMERICAN CYANAMID CO (US) | 2001-06-13 | — | — | CN | disclosed |
| CN-1295480-A | Vaccines comprising interleukin-12 and respiratory syncytial viral antigens | AMERICAN CYANAMID CO (US) | 2001-05-16 | — | — | CN | disclosed |
| CN-1292706-A | Pneumococcal and meningococcal vaccines formulated with interleukin-12 | AMERICAL CYANAMID COMPANY (US) | 2001-04-25 | — | — | CN | disclosed |
| EP-0775168-A1 | METHOD FOR PRODUCING CONDENSATION POLYMERS OF ASPARTIC ACID AND USE OF THE CONDENSATION POLYMERS | BASF AKTIENGESELLSCHAFT (DE) | 1997-05-28 | — | — | EP | disclosed |
| WO-1996005242-A1 | METHOD FOR PRODUCING CONDENSATION POLYMERS OF ASPARTIC ACID AND USE OF THE CONDENSATION POLYMERS | BASF AKTIENGESELLSCHAFT (DE) | 1996-02-22 | — | — | WO | disclosed |